http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2296993-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30baebf6f5fdb4cb09c937486a4e5382
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
filingDate 2005-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fef7a15cb47ac5fa0c34326026b15d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c487eb0a8c798ca7b9cfc16cf52355b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4427622c9994cc61b78a6ed8ffbde23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78e4789ccf83fb9194333462ce4602ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54783f16153389a66290f696f04dfec5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320cced45b910999ad5a3fa24a30ae47
publicationDate 2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2296993-C2
titleOfInvention Method for predicting the type of parturition abnormalities
abstract FIELD: medicine, laboratory diagnostics. n SUBSTANCE: one should detect erythrocytic osmoresistance in the presence of β-adrenoblocator - 1-(1-isopropylamino)-3-(1-naphthalenyl-oxy)-2-propanol hydrochloride and at its value of osmoresistance being below 65 c.u. it is necessary to predict the development of hypotonic uterine dysfunctions at the stage of preliminary period and the first stage of parturition, and at the value of 80 c.u. and more - hypertonic uterine dysfunctions as pathological preliminary period, dystocia of uterine cervix and discoordinated parturition activity. The innovation enables to predict abnormalities of parturition at preclinical stage. n EFFECT: higher accuracy and efficiency of prediction. n 4 ex, 2 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2490644-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623037-C2
priorityDate 2005-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454583680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859022
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4813803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100152272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5020
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280363

Total number of triples: 38.